Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peripheral neurological paraneoplastic syndromes.

M R Pranzatelli1

  • 1The National Pediatric Myoclonus Center and the Department of Pharmacology, The George Washington University, Washington, DC 20004, USA.

Drugs of Today (Barcelona, Spain : 1998)
|February 28, 2004
PubMed
Summary

Peripheral neurological paraneoplastic syndromes are rare autoimmune disorders linked to occult tumors. Early diagnosis via specialized tests and targeted treatment of both the tumor and immune response are crucial for patient improvement.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cerebrospinal fluid γδ T cell frequency is age-related: a case-control study of 435 children with inflammatory and non-inflammatory neurological disorders.

Clinical and experimental immunology·2018
Same author

6-Mercaptopurine modifies cerebrospinal fluid T cell abnormalities in paediatric opsoclonus-myoclonus as steroid sparer.

Clinical and experimental immunology·2017
Same author

Expression of CXCR3 and its ligands CXCL9, -10 and -11 in paediatric opsoclonus-myoclonus syndrome.

Clinical and experimental immunology·2013
Same author

Neurometabolic effects of ACTH on free amino compounds in opsoclonus-myoclonus syndrome.

Neuropediatrics·2008
Same author

B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes.

Neurology·2004
Same author

Central neurological paraneoplastic syndromes. Part 1. Clinical features, pathophysiology and immunopharmacology.

Drugs of today (Barcelona, Spain : 1998)·2004

Area of Science:

  • Neurology
  • Immunology
  • Oncology

Background:

  • Peripheral neurological paraneoplastic syndromes are autoimmune disorders associated with occult malignancies.
  • These syndromes represent a significant cause of neurological disability and mortality.
  • They encompass conditions affecting peripheral nerves, nerve roots, neuromuscular junctions, and muscles.

Purpose of the Study:

  • To provide an overview of peripheral neurological paraneoplastic syndromes.
  • To highlight their importance as indicators of underlying tumors.
  • To discuss diagnostic approaches and treatment strategies.

Main Methods:

  • Review of existing literature on peripheral neurological paraneoplastic syndromes.
  • Discussion of diagnostic tools including electrophysiological studies, autoantibody screening, CSF analysis, and biopsies.

Related Experiment Videos

  • Emphasis on identifying and treating the associated occult tumor and immunological factors.

    • Main Results:

    • Peripheral neurological paraneoplastic syndromes are diverse, affecting various parts of the peripheral nervous system.
    • Specific neurological targets include calcium channels (Lambert-Eaton myasthenic syndrome) and acetylcholine receptors (myasthenia gravis).
    • Diagnosis relies on a combination of neurological assessment and specific laboratory and imaging techniques.

    Conclusions:

    • Early diagnosis and multidisciplinary management are essential for improving outcomes.
    • Treatment involves addressing the primary tumor and modulating the immune response.
    • Supportive care and symptomatic therapies play a vital role in patient management.